These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25445578)

  • 1. Re: Overactive bladder changes with time: a 5-year longitudinal followup of changes in overactive bladder symptoms, urodynamic studies and urinary nerve growth factor levels: F.-C. Chuang, H.-T. Liu, L.-Y. Wang and H.-C. Kuo J Urol 2014; 192: 458-463.
    Agilli M; Aydin FN; Kurt YG; Cayci T
    J Urol; 2015 Feb; 193(2):737. PubMed ID: 25445578
    [No Abstract]   [Full Text] [Related]  

  • 2. Overactive bladder changes with time: a 5-year longitudinal followup of changes in overactive bladder symptoms, urodynamic studies and urinary nerve growth factor levels.
    Chuang FC; Liu HT; Wang LY; Kuo HC
    J Urol; 2014 Aug; 192(2):458-63. PubMed ID: 24594404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder.
    Liu HT; Kuo HC
    J Urol; 2008 Jun; 179(6):2270-4. PubMed ID: 18423678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [NERVE GROWTH FACTOR IN THE URINE OF PATIENTS WITH IDIOPATHIC DETRUSOR OVERACTIVITY AND OVERACTIVE BLADDER WITHOUT DETRUSOR OVERACTIVITY].
    Krivoborodov GG; Kolesanova EF; Tur EI; Efremov NS
    Urologiia; 2015; (3):19-22. PubMed ID: 26390554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NGF and HB-EGF: potential biomarkers that reflect the effects of fesoterodine in patients with overactive bladder syndrome.
    Kim SR; Moon YJ; Kim SK; Bai SW
    Yonsei Med J; 2015 Jan; 56(1):204-11. PubMed ID: 25510766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Have we been led astray by the NGF biomarker data?
    Gamper M; Moser R; Viereck V
    Neurourol Urodyn; 2017 Jan; 36(1):203-204. PubMed ID: 26384156
    [No Abstract]   [Full Text] [Related]  

  • 7. Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention.
    Liu HT; Kuo HC
    Neurourol Urodyn; 2009; 28(1):78-81. PubMed ID: 19089891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overactive bladder and underactive bladder: a symptom syndrome or urodynamic diagnosis?
    Chapple C
    Neurourol Urodyn; 2013 Apr; 32(4):305-7. PubMed ID: 23592009
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary nerve growth factor and a variable solifenacin dosage in patients with an overactive bladder.
    Ciftci S; Ozkurkcugil C; Yilmaz H; Ustuner M; Yavuz U; Yuksekkaya M; Cekmen MB
    Int Urogynecol J; 2016 Feb; 27(2):275-80. PubMed ID: 26310546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary nerve growth factor in children with overactive bladder: a promising, noninvasive and objective biomarker?
    Ergin G; Ebiloglu T; Kibar Y; Kopru B
    J Pediatr Urol; 2014 Oct; 10(5):976. PubMed ID: 25104420
    [No Abstract]   [Full Text] [Related]  

  • 11. Urinary nerve growth factor in children with overactive bladder: a promising, noninvasive and objective biomarker.
    Oktar T; Kocak T; Oner-Iyidogan Y; Erdem S; Seyithanoglu M; Ziylan O; Kocak H
    J Pediatr Urol; 2013 Oct; 9(5):617-21. PubMed ID: 22789557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder.
    Yokoyama T; Kumon H; Nagai A
    Neurourol Urodyn; 2008; 27(5):417-20. PubMed ID: 17924444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary neurotrophic factors in healthy individuals and patients with overactive bladder.
    Antunes-Lopes T; Pinto R; Barros SC; Botelho F; Silva CM; Cruz CD; Cruz F
    J Urol; 2013 Jan; 189(1):359-65. PubMed ID: 23174241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential biomarker for objective diagnosis of overactive bladder: urinary nerve growth factor.
    Agilli M; Aydin FN; Kurt YG; Cayci T
    Int Urol Nephrol; 2015 Feb; 47(2):317-8. PubMed ID: 25425438
    [No Abstract]   [Full Text] [Related]  

  • 15. Rebuttal comments on "a potential biomarker for objective diagnosis of overactive bladder: urinary nerve growth factor".
    Hai B
    Int Urol Nephrol; 2015 Feb; 47(2):319. PubMed ID: 25532476
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of urinary nerve growth factor for the diagnosis and assessment of the biofeedback success in children with dysfunctional voiding.
    Ergin G; Kibar Y; Ebiloğlu T; Irkılata HC; Kopru B; Kaya E; Uyanık M; Tapan S; Dayanc MM
    J Pediatr Urol; 2016 Apr; 12(2):118.e1-6. PubMed ID: 26701107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients.
    Jacobs BL; Smaldone MC; Tyagi V; Philips BJ; Jackman SV; Leng WW; Tyagi P
    Can J Urol; 2010 Feb; 17(1):4989-94. PubMed ID: 20156378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could urinary nerve growth factor be a biomarker for overactive bladder? A meta-analysis.
    Sheng W; Zhang H; Ruth KH
    Neurourol Urodyn; 2017 Sep; 36(7):1703-1710. PubMed ID: 28102552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel biomarkers of overactive bladder syndrome.
    Wróbel AF; Kluz T; Surkont G; Wlaźlak E; Skorupski P; Filipczak A; Rechberger T
    Ginekol Pol; 2017; 88(10):568-573. PubMed ID: 29192418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary nerve growth factor: a biomarker of detrusor overactivity? A systematic review.
    Rachaneni S; Arya P; Latthe P
    Int Urogynecol J; 2013 Oct; 24(10):1603-9. PubMed ID: 23649686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.